Supplementary Table 1: Wound Healing Outcomes in Skin Cancer Patients on Sirolimus: Insights from Dermatologic Surgery

Supplementary Table 1. Complication rates by defect depth (dermis/fat, fascia, muscle, cartilage/bone) for tumors treated with sirolimus and tacrolimus. Includes relative risks and overall trends across increasing defect depths.补充表1. 接受西罗莫司（sirolimus）与他克莫司（tacrolimus）治疗的肿瘤患者，按缺损深度（真皮/脂肪、筋膜、肌肉、软骨/骨）划分的并发症发生率，包含相对风险值以及缺损深度递增时的整体变化趋势。